“…Although prior analyses are conflicting, the preponderance of evidence suggests that women are more likely to experience in-hospital mortality and complications. 4,[22][23][24][25][26][27][28][29][30][31][32][33] Various studies have hypothesized that this increased risk is due to a greater burden of comorbidities, older age, smaller body size, and/or less aggressive pharmacological therapy. Yet, in our study, women remained at a significantly increased risk despite extensive adjustment for Ͼ50 clinical variables, including those mentioned by other authors such as clinical risk profile, age, body surface area, kidney disease, antiplatelet and anticoagulant therapy, and acuity of disease.…”